The big pictureI do hope everyone understands what is coming their way in the next several weeks. There will most likely be several assays released with far, far higher grades than what was reported with their first hole. Now, the questions are, how much higher, and over what type of intervals?
Not selling a share here personally and would add on any appreciable weakness (90 cents?). Not likely it sees those levels but you never know for sure:)
Big picture, 2021 will be the real coming out party for ESK and its shareholders. Be positioned accordingly.